Capstone Financial Advisors, Inc. Bristol Myers Squibb CO Transaction History
Capstone Financial Advisors, Inc.
- $1.72 Billion
- Q2 2025
A detailed history of Capstone Financial Advisors, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Capstone Financial Advisors, Inc. holds 18,324 shares of BMY stock, worth $832,825. This represents 0.05% of its overall portfolio holdings.
Number of Shares
18,324
Previous 17,747
3.25%
Holding current value
$832,825
Previous $1.08 Million
21.63%
% of portfolio
0.05%
Previous 0.07%
Shares
20 transactions
Others Institutions Holding BMY
# of Institutions
2,676Shares Held
1.64BCall Options Held
22.4MPut Options Held
25.4M-
Vanguard Group Inc Valley Forge, PA195MShares$8.86 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.21 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.91 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.31 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.22 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $96.6B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...